For the Inventor, By the Inventor

Enter assignee name

La Jolla, CA, United States of America

Scripps Research Institute

Calculating rank

USPTO Granted Patents = 1,208

% Expired Patents = 23.5

CIPO Patents = 29

EPO Patents = 255

Trademarks = 3

Forward Citations = 16,192

Loading Chart...

Loading Chart...

1,354 inventors (with patents filed for the assignee):

Peter G Schultz (143 out of 213 patents)

Chi-Huey Wong (66 out of 174 patents)

Richard A Lerner (65 out of 87 patents)

4. Dennis R Burton (51 out of 56 patents)

5. Carlos F Barbas, Iii (49 out of 51 patents)

6. Dale L Boger (45 out of 48 patents)

7. Sheng Ding (40 out of 53 patents)

8. K Barry Sharpless (34 out of 45 patents)

9. Kim D Janda (33 out of 36 patents)

10. Zhiwen Zhang (33 out of 33 patents)

11. Kyriacos Costa Nicolaou (32 out of 60 patents)

12. Benjamin F Cravatt (31 out of 31 patents)

13. Lei Wang (31 out of 303 patents)

14. Mark H Ginsberg (28 out of 34 patents)

15. Jason W Chin (24 out of 34 patents)

Core Competencies:

HIV Antibodies

Cancer Therapies

Peptide Vaccines

Antiviral Prodrugs

Immunogenic Proteins

Stem Cell Methods

Modified Therapeutic Agents

Chimeric Antigen Receptors

Unnatural Nucleotides

Ebola Virus Antibodies

Small Molecule Inhibitors

Vaccine Design

1,208 patents: Sort by Forward Citations

1. 12760046 - Phosphorous (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophoshorous (V) compounds (2026-10-13),

2. 12758557 - Small molecule regulators of alveolar type 2 cell proliferation for the treatment of pulmonary diseases (2026-10-13),

3. 12752014 - Disruption of CD28-sialoside ligand complexes to enhance T cell activation (2026-10-06),

4. 12748111 - Methods for detection of pathogenic antiphospholipid antibodies and for identification of inhibitors (2026-09-29),

5. 12741937 - Tautomeric ligand enables biomimetic C—H hydroxylation with molecular oxygen (2026-09-22),

6. 12728169 - Immune cell receptor antibodies conjugated to high affinity siglec-ligands (2026-09-08),

7. 12723039 - Small molecule inhibitors of SLC15A4 with anti-inflammatory activity (2026-09-01),

8. 12679869 - RECOMBINANT HIV ENV POLYPEPTIDES AND THEIR USES (2026-07-14),

9. 12662677 - CHIMERIC POLYPEPTIDES HAVING TARGETED BINDING SPECIFICITY (2026-06-23),

10. 12655436 - IMPORT OF UNNATURAL OR MODIFIED NUCLEOSIDE TRIPHOSPHATES INTO CELLS VIA NUCLEIC ACID TRIPHOSPHATE TRANSPORTERS (2026-06-16),

11. 12642848 - Immunogenic trimers (2026-06-02),

12. 12637520 - NOVEL CONJUGATION CHEMISTRY FOR CATALYTIC ANTIBODY 38C2 (2026-05-26),

13. 12630550 - PHARMACOPHORE FOR TRAIL INDUCTION (2026-05-19),

14. 12617843 - HUMAN BROADLY NEUTRALIZING ANTIBODIES AGAINST THE MEMBRANE-PROXIMAL EXTERNAL REGION OF HIV ENV FOR VACCINE DESIGN AND INTERVENTION (2026-05-05),

15. 12617757 - COMPOUNDS AND MODULES FOR INHIBITION OF PRE-miR-21 AND THEIR USE IN TREATMENT OF CERTAIN CANCERS (2026-05-05),

Company Overview

Scripps Research Institute, located in La Jolla, California, is a leading nonprofit biomedical research organization focused on advancing biopharmaceutical innovations. The institute specializes in the development of groundbreaking therapies, including HIV antibodies, cancer treatments, and peptide vaccines. Its research encompasses a wide array of core technology topics such as antiviral prodrugs, immunogenic proteins, stem cell methods, modified therapeutic agents, and chimeric antigen receptors, contributing significantly to the fields of medicine and biotechnology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

1,208 Patents

#1 in La Jolla, CA

#105 in California

#431 in US

#850 in the World

La Jolla, CA, United States of America

Scripps Research Institute

Forward Citations = 16,192

1,354 inventors:

Peter G Schultz (143 out of 213 patents)

Chi-Huey Wong (66 out of 174 patents)

Richard A Lerner (65 out of 87 patents)

4. Dennis R Burton (51 out of 56 patents)

5. Carlos F Barbas, Iii (49 out of 51 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Scripps Research Institute. Retrieved from https://idiyas.com/company/scripps-research-institute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…